Immunoglobulin G4-Related Disease Clinical Trials

10 clinical trials for Immunoglobulin G4-Related Disease across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — RECRUITING · PHASE3
• Open-label, Uncontrolled, Multicenter Trial to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Children From 2 Years to Less Than 18 Years of Age with Immunoglobulin G4 related Disease (IgG4-RD) — RECRUITING · PHASE2
• Institutional Registry of Rare Diseases — RECRUITING
• Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms — RECRUITING
• Efficacy and Safety of Lenalidomide in Patients With IgG4-Related Disease — NOT_YET_RECRUITING · PHASE3
• Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD — NOT_YET_RECRUITING · PHASE2
• A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in IgG4-Related Disease. — TERMINATED · PHASE3
• Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants — COMPLETED · PHASE2
• Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target — NOT_YET_RECRUITING · NA
• Diagnostic and Prognostic Biomarkers for IgG4-related Disease. — OTHER

Refine this search